Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Gordon

Showing results (41-50 of 234) with videos related to

Pageof 24
Sort By:
Annals of the Rheumatic Diseases|June 22, 2014
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)David Isenberg, Caroline Gordon, Daiana Licu, et al.
Rheumatology (Oxford, England)|August 8, 2007
Ocular manifestations of systemic lupus erythematosusR R Sivaraj, O M Durrani, A K Denniston, et al.
Annals of the Rheumatic Diseases|January 14, 2019
Current challenges in the development of new treatments for lupusMaria Dall'Era, Ian N Bruce, Caroline Gordon, et al.
Arthritis Care & Research|October 28, 2016
Prevalence of Mixed Connective Tissue Disease in a Population-Based Registry of American Indian/Alaska Native People in 2007Elizabeth D Ferucci, Janet M Johnston, Caroline Gordon, et al.
Arthritis and Rheumatism|December 30, 2009
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trialEllen M Ginzler, David Wofsy, David Isenberg, et al.
Arthritis Research & Therapy|July 29, 2021
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory modelsJohn A Reynolds, Jennifer Prattley, Nophar Geifman, et al.
Rheumatology (Oxford, England)|September 20, 2013
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online surveyCaroline Gordon, David Isenberg, Kirsten Lerstrøm, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2017
The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance ProjectMaria Dall'Era, Miriam G Cisternas, Kurt Snipes, et al.
Clinical Rheumatology|January 18, 2012
Refractory multisystem sarcoidosis responding to infliximab therapyAdam P Croft, Deva Situnayake, Omer Khair, et al.
Survey of Ophthalmology|July 22, 2015
Systemic lupus erythematosus: An update for ophthalmologistsEfrosini Papagiannuli, Benjamin Rhodes, Graham R Wallace, et al.
Pageof 24

Showing results (41-50 of 234) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|June 22, 2014
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)David Isenberg, Caroline Gordon, Daiana Licu, et al.
Rheumatology (Oxford, England)|August 8, 2007
Ocular manifestations of systemic lupus erythematosusR R Sivaraj, O M Durrani, A K Denniston, et al.
Annals of the Rheumatic Diseases|January 14, 2019
Current challenges in the development of new treatments for lupusMaria Dall'Era, Ian N Bruce, Caroline Gordon, et al.
Arthritis Care & Research|October 28, 2016
Prevalence of Mixed Connective Tissue Disease in a Population-Based Registry of American Indian/Alaska Native People in 2007Elizabeth D Ferucci, Janet M Johnston, Caroline Gordon, et al.
Arthritis and Rheumatism|December 30, 2009
Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trialEllen M Ginzler, David Wofsy, David Isenberg, et al.
Arthritis Research & Therapy|July 29, 2021
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory modelsJohn A Reynolds, Jennifer Prattley, Nophar Geifman, et al.
Rheumatology (Oxford, England)|September 20, 2013
The substantial burden of systemic lupus erythematosus on the productivity and careers of patients: a European patient-driven online surveyCaroline Gordon, David Isenberg, Kirsten Lerstrøm, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 12, 2017
The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance ProjectMaria Dall'Era, Miriam G Cisternas, Kurt Snipes, et al.
Clinical Rheumatology|January 18, 2012
Refractory multisystem sarcoidosis responding to infliximab therapyAdam P Croft, Deva Situnayake, Omer Khair, et al.
Survey of Ophthalmology|July 22, 2015
Systemic lupus erythematosus: An update for ophthalmologistsEfrosini Papagiannuli, Benjamin Rhodes, Graham R Wallace, et al.
Pageof 24